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Entry of simian immunodeficiency virus (SIV) into cells is mediated by binding of the viral envelope (Env) glycoprotein to cellular CD4
and chemokine receptor molecules. Interaction of the Env gp120 subunit with CD4 induces conformational changes that result in exposure of
a conserved coreceptor binding site. The chemokine receptor CCR5 is the major coreceptor used for SIV entry. Many SIV Envs have the
ability to bind directly to CCR5 in the absence of CD4, and CD4-independent SIVs have been shown to exhibit macrophage tropism,
enhanced neutralization sensitivity, and reduced pathogenicity in nonhuman primates. SIVmac239 is a pathogenic, T-tropic, neutralization-
resistant virus which encodes a CD4-dependent Env. By contrast, the SIVmac316 virus, which differs from 239 in Env by only eight amino
acid substitutions and a gp41 cytoplasmic domain truncation, exhibits macrophage tropism in vitro, attenuated pathogenesis, neutralization
sensitivity, and CD4-independent entry. We mapped the residues contributing to CD4-independent entry to substitutions at position 165 in the
V1/V2 region of gp120 and position 573 of gp41. We find that substitution of both residues in replication-competent SIVmac239 virus results
in gain of CD4 independence and enhanced neutralization sensitivity. By contrast, the converse substitutions placed in the background of
SIVmac316 resulted in loss of CD4 independence and decreased neutralization sensitivity. Thus, as few as two amino acid changes can have
dramatic effects on SIV Env phenotype.
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Entry of primate immunodeficiency viruses into target
cells requires the interaction of viral envelope (Env) glyco-
proteins with cellular receptors (reviewed in Pierson and
Doms, 2003). Env is present on the surface of the virion as a
trimer composed of three gp120 surface subunits associated
with three gp41 transmembrane subunits (Zhu et al., 2003).
The gp120 subunit initiates virus entry through high-affinity
interactions with the cellular CD4 molecule. This induces
dramatic conformational changes in Env, which result in
exposure of a highly conserved coreceptor binding site that is
obscured in the native Env structure (Kwong et al., 2002;
Rizzuto and Sodroski, 2000; Sattentau et al., 1993; Wyatt et0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: doms@mail.med.upenn.edu (R.W. Doms).al., 1995). This CD4 triggered Env then engages a corecep-
tor, with CCR5 being the major coreceptor utilized by simian
immunodeficiency virus (SIV) strains. Coreceptor binding
triggers conformational changes in the gp41 subunit that lead
to insertion of an amino terminal fusion peptide into the
target cell membrane. This process ultimately results in
fusion between the viral and cellular membranes, and depos-
its the viral core into the cytoplasm of the host cell.
Many primary HIV-2 and SIV strains have been identi-
fied that have a reduced requirement for CD4 during virus
entry. These viruses have been shown to infect cells with
low to undetectable levels of CD4 more efficiently than
other virus strains (Dumonceaux et al., 1998; Edinger et al.,
1997; Endres et al., 1996; Reeves et al., 1997). Recently, the
R2 primary HIV-1 isolate was demonstrated to infect
reporter cell lines expressing CCR5 in the absence of CD4
(Zhang et al., 2002). This phenotype was mapped to an
unusual proline substitution in the V3 loop (Zhang et al.,
2002). Similarly, fine analyses of lab-adapted HIV-1 Envs
indicate that CD4 independence can result from only a few,
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Kolchinsky et al., 1999; LaBranche et al., 1999). Thus, it is
interesting that such variants do not arise in vivo more
frequently. However, we and others have found that the
CD4-independent phenotype is associated with markedly
enhanced sensitivity to antibody-mediated neutralization
(Kolchinsky et al., 2001; Puffer et al., 2002). In contrast
to HIV-1, studies in the rhesus macaque model have
identified numerous CD4-independent SIV strains (Deh-
ghani et al., 2003; Edinger et al., 1997, 1999a, 1999b;
Reeves et al., 1999). These viruses were derived from
tissues of immunocompromised macaques, or from brain
tissue, an immune-privileged site. Taken together, these data
indicate that CD4-independent variants become common
only in the absence of the selective pressure of the humoral
immune response.
Functional characterization of HIV-1, HIV-2, and SIV-
mac strains has identified several features that are asso-
ciated with CD4 independence. HIV-1 Envs that can
facilitate CD4-independent entry have been shown to
stably expose the coreceptor binding site, a structure
normally masked by variable loops (Hoffman et al.,
1999; Kwong et al., 2002). Reeves and Schulz (1997)
demonstrated that CD4-independent HIV-2 Envs are more
easily triggered with soluble CD4 and bind to human
CD4 with higher affinity than CD4-dependent Envs. In
the SIV system, CD4-independent isolates exhibit expand-
ed tropism by gaining the ability to infect CD4-negative
cells that express CCR5 and macrophages because rhesus
macrophages express very low levels of CD4 on their
surface (Bannert et al., 2000; Edinger et al., 1997; Mori
et al., 2000). Thus, CD4-independent entry is a hallmark
of functional changes in the Env that can include en-
hanced receptor affinity, exposure of critical domains, and
expanded tropism.
In this study, we identified structural determinants within
gp120 and gp41 that contribute to CD4 independence of the
SIVmac316 Env, a variant of the CD4-dependent SIV-
mac239 virus. We demonstrate that substitution of only
two residues within the 239 Env confers a CD4-independent
phenotype while substitution at the same positions in the
316 Env abrogates CD4-independent function. These two
substitutions also conferred neutralization sensitivity and
altered Env affinity for rhesus CD4.Fig. 1. Location of substitutions within 239 gp120 and gp41. SIVmac239 gp160
gp41. Also designated are the leader peptide sequence, variable regions V1/2 and V
are designated by residue and number.Results
Structural comparison of SIVmac239 and SIVmac316 Envs
The SIVmac239 and SIVmac316 Env proteins differ by
only eight amino acid substitutions and a truncation in gp41,
yet they have different phenotypes. SIVmac239 requires
CD4 for entry into target cells, is restricted to replication in
T cells, acutely pathogenic, and neutralization resistant
(Kestler et al., 1989; Naidu et al., 1988). In contrast,
SIVmac316 has the ability to infect CD4-negative cells
expressing the CCR5, GPR15, or STRL33 receptors, infects
both macrophage and T cells, exhibits attenuated pathoge-
nicity, and is sensitive to antibody-mediated neutralization
(Means et al., 2001; Mori et al., 1992, 1993; Puffer et al.,
2002). Comparison of 239 and 316 gp160s identifies six
amino acid substitutions in gp120 (V67/M, M165/I, K176/
E, N199/D, G382/R, and H442/Y), two in gp41 (K573T,
R751G), and a cytoplasmic domain truncation (Fig. 1).
Previous studies of these substitutions indicate that the
combination of V67/M, K176/E, and G382R impart mac-
rophage tropism when introduced into the SIVmac239 Env
protein; this genetically modified virus is called SIV-
macMER (Kodama et al., 1993; Mori et al., 1992). In
addition, the lysine 573 substitution enhances macrophage
tropism of MER (Mori et al., 2000). Lysine 573 lies in
helical region 1 (HR1) of the gp41 ectodomain, a domain
involved in conformational rearrangements of the gp41
subunit that ultimately result in membrane fusion. The
effects of these mutations on other Env-dependent pheno-
types, such as neutralization sensitivity and CD4 depen-
dence, are not known.
In addition, other substitutions may contribute to a CD4-
independent phenotype. For example, substitution of aspar-
agine 199 with an acidic residue is common among the
CD4-independent Envs 1A11, 1100, and CP-MAC. A
glycine 382 to arginine change, which maps within the
highly conserved CD4 binding site, is also present in the
1100 and 17E-Fr CD4-independent Envs (Anderson et al.,
1993; Strelow et al., 1998). Finally, truncation of the gp41
cytoplasmic domain has been implicated in enhanced CD4-
independent entry, exposure of the coreceptor binding site,
and reduced pathogenicity of viral isolates (Edwards et al.,
2002; Shacklett et al., 2000).is represented with the white box defining gp120 and gray box indicating
3, transmembrane and helical regions. SIVmac316 amino acid substitutions
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and MER Envs
We first examined the relative fusogenicity and CD4-
independent function of the 239 and 316 Envs in a cellular
fusion assay (Fig. 2). In this assay, cells expressing Env were
mixed with cells transfected with rhesus (Rh) or human (Hu)
CCR5 and CD4, and fusion of the cell types detected by
expression of luciferase reporter that occurred only upon
cytoplasmic mixing. We found that 316 expressing cells
B.A. Puffer et al. / V18Fig. 2. Evaluation of 239-, 316-, and MER-derived Env fusion with human
and rhesus receptors. Fusion assays were performed using QT6 target cells
transfected with the designated human (A) or rhesus (B) receptor plasmids
and a T7 promoter-driven luciferase construct. Twenty-four hours post-
transfection, effector cells expressing the designated Env and T7
polymerase were added to the target cells. Approximately 8–10 h after
mixing, cells were lysed with PBS–0.5% Triton X-100 and assayed for
luciferase activity. Black bars indicate fusion with CCR5 and CD4, gray
bars indicate CD4-independent fusion, white bars indicate fusion observed
with CD4 only. Data from at least three experiments were averaged and
error bars indicate the standard error of the mean.mediated fusion more readily with targets than was observed
with 239 bearing cells. The 239 Env was less fusogenic than
the 316 Env with cells expressing either RhCCR5 and
RhCD4 or HuCCR5 and HuCD4 (Fig. 2A). 316 also
facilitated fusion in a CD4-independent fashion, fusing with
cells expressing RhCCR5 or HuCCR5 alone, while 239
fused efficiently only when both CD4 and CCR5 were
present (Figs. 2B, C, respectively). This was more pro-
nounced when rhesus receptors were used. This difference
had previously been attributed to electrostatic interactions
between the Env and an aspartic acid residue at position 13 in
CCR5 (Edinger et al., 1999a, 1999b; Lin et al., 2001). To
address the concern that truncation of the 316 gp41 cyto-
plasmic domain may have induced the enhanced fusogenic-
ity or CD4 independence, a 316 Env with a full-length
cytoplasmic tail was tested (316 open). This Env maintained
fusogenicity comparable to 316 (Fig. 2A) and exhibited
enhanced CD4-independent fusion with cells expressing
either rhesus or human CCR5 (Figs. 2B, C, respectively).
Thus, determinants of CD4 independence could not be
attributed to truncation of the 316 cytoplasmic tail.
MER is a macrophage tropic variant of the 239 Env that
was generated during a study mapping the determinants of
macrophage tropism (Mori et al., 1992). This Env contains
the three substitutions V67M, K176E, and G382R in the
239 Env. We next examined the MER Env to determine if
substitutions attributed to macrophage tropism also facili-
tated CD4 independence. Combination mutants in the 316
background were examined in fusion assays to determine if
replacement of the MER substitutions at positions 67, 176,
and 382 would abrogate CD4 independence. The MER Env
fused similarly to 316 when both CD4 and CCR5 were
present (Fig. 2A), but functioned CD4 independently at only
half the efficiency of 316 with RhCCR5 (Fig. 2B), and very
poorly with HuCCR5 (Fig. 2C). We observed that both
316(MR) and 316(MER) fused less efficiently than 316
in the presence of CD4 with either the rhesus or human
homologs (Fig. 2A), yet maintained that level of fusion with
cells expressing RhCCR5 alone (Fig. 2B). Both were greatly
diminished in their ability to utilize HuCCR5 independent
of CD4 (Fig. 2C). These results indicate that the MER
substitutions do facilitate CD4 independence with RhCCR5,
although more efficient CD4 independence can be attained
through other substitutions.
Contribution of individual residues to gain of
CD4-independent function by the 239 Env
We next examined a series of 239 mutants containing the
single amino acid substitutions found in the 316 Env to see if
they conferred a CD4-independent phenotype. Each of these
eight Envs was examined by cellular fusion assays to
identify any contribution to CD4-independent function. We
observed that each of the 239 Envs encoding point mutations
maintained an ability to fuse with cells expressing both
CCR5 and CD4 with at least half the efficiency compared
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substitutions enhanced CD4-independent fusion to a modest
degree, a significant enhancement was obtained with the
gp120 M165I (P = 0.0009; Student’s t test) and gp41 K573T
(P = 0.0011) changes. We observed that the enhancement
was more pronounced when fusion occurred with cells
expressing RhCCR5 rather than HuCCR5 (Figs. 3B, C),
consistent with the greater fusogenicity on rhesus receptors
noted above. Thus, no single amino acid change greatly
affected the overall fusogenicity of 239 Env, though multiple
changes enhanced CD4-independent fusion activity.Fig. 3. Gain of CD4-independent function by substitution of single residues
in 239 gp160. Fusion assays were performed as described (see Fig. 2). QT6
target cells transfected with the designated (A) human or (B) rhesus
receptors and a T7 promoter-driven luciferase reporter construct was mixed
with cells bearing the designated Env and T7 polymerase. Approximately
8–10 h post-mixing, the cells were lysed and analyzed for luciferase
activity. Black bars indicate fusion with CCR5 and CD4, gray bars indicate
CD4-independent fusion, white bars indicate fusion observed with CD4
only. Values were normalized to 239 fusion with RhCCR5- and RhCD4-
bearing cells. Data from at least three experiments were averaged. Error
bars indicate the standard error of the mean.
Fig. 4. Loss of CD4-independent function by substitution of single residues
in 316. Fusion assays were performed as described (see Fig. 2). QT6 target
cells transfected with the designated (A) human or (B) rhesus receptors and
a T7 promoter-driven luciferase reporter construct was mixed with cells
bearing the designated Env and T7 polymerase. Approximately 8 h post-
mixing, the cells were lysed and analyzed for luciferase activity. Black bars
indicate fusion with CCR5 and CD4, gray bars indicate CD4-independent
fusion, white bars indicate fusion observed with CD4 only.Contribution of individual substitutions to loss of
CD4-independent function by the 316 Env
Having demonstrated a gain of CD4-independent func-
tion by the 239 Env with only minor substitutions, we next
analyzed the reciprocal point mutations in the 316 Env to
determine if any resulted in loss of CD4-independent
function. Cellular fusion assays were performed with the
eight single point mutations. Each of the Envs exhibited
efficient fusion with cells expressing both CCR5 and CD4,
though several changes reduced overall fusion levels close
to those obtained with 239 Env (G751R, T573K, and
Y442H) (Fig. 4A). No single mutation greatly diminished
CD4-independent function of the Env with RhCCR5, but
Fig. 6. Neutralization sensitivity of replication-competent viruses encoding
substitutions at positions 165 and 573. Virus stocks were generated by
B.A. Puffer et al. / Virology 327 (2004) 16–2520CD4-independent use of HuCCR5 was significantly re-
duced by changes at positions 165 (P = 0.04), 382 (P =
0.01), and 573 (P = 0.03). Because changes at positions
165 and 573 had the greatest effect on CD4-independent
function in the context of both 239 and 316, we next
examined combination mutants involving both the 165
and 573 positions. The Env 239(M165I, K573T) was
slightly more fusogenic than 239 and exhibited enhanced
CD4-independent function with either RhCCR5 (P = 0.02)
or HuCCR5 (P = 0.006) (Fig. 5), while Env 316(I165M,
T573K) was less fusogenic than 316 and exhibited signif-
icantly decreased CD4-independent fusion with RhCCR5
(P = 0.025) and HuCCR5 (P = 0.012) (Fig. 5). Thus, weFig. 5. Relative CD4 independence of Envs substituted at both positions
165 and 573. Fusion assays were performed as described (see Fig. 2). QT6
target cells transfected with the designated (A) human or (B) rhesus
receptors and a T7 promoter-driven luciferase reporter construct was mixed
with cells bearing the designated Env and T7 polymerase. Approximately
8 h post-mixing, the cells were lysed and analyzed for luciferase activity.
Black bars indicate fusion with CCR5 and CD4, gray bars indicate CD4-
independent fusion, white bars indicate fusion observed with CD4 only.
transfection of HEK 293T cells with the molecular proviral clone for the
designated virus and normalized for the ability to infect GHOST CD4-
CCR5 cells. Viral supernatants were incubated with the designated dilution
of rhesus serum in complete medium for 1 h at 37 jC with 5% CO2. Virus
and serum were then added to GHOST CD4-CCR5 target cells and cells
were placed at 37 jC. Approximately 36 h after inoculation, cells were
washed three times with PBS–EDTA and fixed with 2% paraformaldehyde.
Green fluorescence was detected and analyzed by FACS (FACScan; BD)
utilizing the Cellquest software package.have identified two amino acid changes that in combination
are both necessary and sufficient for CD4-independent
membrane fusion, though other changes in Env can clearly
affect the efficiency of this process.
Relative sensitivities of recombinant viruses to
neutralization
To address whether two substitutions were sufficient to
alter the neutralization sensitivity of the Envs, recombinant
viruses encoding the identified changes were generated.
Replication-competent viruses were produced by transfec-
tion of HEK 293T cells and sensitivity to pooled serum from
239 infected rhesus macaques was determined utilizing the
Ghost cell system (Morner et al., 1999). It has previously
been demonstrated that SIVmac239 virus and pseudotypes
bearing the 239 Env are more resistant to neutralization by
serum from 239 infected macaques than are viruses with the
316 Env (Means et al., 2001; Puffer, 2002). We demonstrate
here using replication-competent viruses that the dual mutant
virus 316(I165M, T573K) demonstrated enhanced neutrali-
zation resistance in comparison to wild-type 316 (P =
0.0003), while 239(M165I,K573T) became more sensitive
to neutralization than wild-type 239 (P = 0.03) (Fig. 6).
Thus, these two amino acid changes affect not only CD4
independence, but neutralization sensitivity as well.
Relative affinity for rhesus CD4
Previous studies have shown that the SIVmac316 gp120
subunit binds human CD4 with a higher affinity than
SIVmac239 gp120, but no studies have examined relative
affinities of these Envs for their natural ligand, RhCD4.
HuCD4 and RhCD4 differ by multiple substitutions in the
Fig. 7. Altered affinity for RhCD4 upon substitution at position 165.
Relative affinity of the parental and mutant Envs was determined by capture
of gp120 protein on G. nivalis-coated plates. Supernatant containing the
RhCD4IgG fusion protein and binding was detected with HRP-conjugated
anti-rabbit antibodies and TM Blue substrate. Absorbance was detected at
optical density (O.D.) 630 nm wavelength in a Dynex MLX plate reader
with Revelation software. Dotted lines indicate relative affinities.
B.A. Puffer et al. / Virologdomains which harbor the binding site for gp120; thus, it is
possible that there are differences in Env affinity for RhCD4
and HuCD4. We examined the relative affinity of 239, 316,
239(M165I), and 316(I165M) gp120s for a RhCD4IgG
fusion protein. We observed that the 316 gp120 binds
RhCD4IgG protein with greater affinity than 239 (Fig. 7).
Furthermore, mutation of position 165 in 316 had little
effect on binding while the reciprocal change in 239 slightly
enhanced RhCD4IgG binding. These data indicate that
position 165 does alter the interaction between gp120 and
RhCD4. However, other substitutions in the 316 Env must
also result in enhanced affinity for RhCD4.Fig. 8. Incorporation of envelope proteins into virions. Virus stocks were normalize
were resolved by a 4–15% PAGE and transferred to PVDF membrane. (A) gp120
p27 and gp41 were detected with pooled immune macaque serum and anti-monkEnv density in virus particles
A feature shared by many CD4-independent, primary SIV
isolates is truncation of the gp41 cytoplasmic domain.
SIVmac316 has a stop codon at position 767, which shortens
the cytoplasmic domain by 112 amino acids. Similar trunca-
tions have been described in the CD4-independent viruses
SIVmac1100, 1A11, 17E-Fr, and 251. The cytoplasmic
domain of gp41 encodes endocytosis signals that limit Env
surface expression (Berlioz-Torrent et al., 1999; Egan et al.,
1996; LaBranche et al., 1995; Ohno et al., 1997; Wyss et al.,
2001). Truncation of gp41 therefore increases the surface
density of Env on both the cell and the virion, enhancing the
avidity by which the virus binds to receptors. While we
observe in cellular fusion assays that a shortened cytoplas-
mic domain is not required for CD4-independent function
(Fig. 2A), the effect on surface expression is masked by
vaccinia-driven overexpression of the Env. To determine if
gp41 truncation results in increased incorporation of Env
onto virus particles, we examined viruses encoding full and
truncated gp41 sequences. Virus stocks were produced,
pelleted through 20% sucrose to remove cellular debris,
and aliquots containing equivalent amounts of p27 were
analyzed by SDS-PAGE andWestern blotting. We found that
viruses containing Envs with shortened cytoplasmic domains
[316 and 316(I165M/K573T) contained significantly more
Env than those with full-length cytoplasmic domains (239,
239(M165/IT573K), 316open, and 316(I65M/K573T) open]
(Fig. 8). Thus, the SIVmac316 Env protein has changes that
impart CD4 independence, enhanced affinity for CD4, and
increased incorporation of Env onto virus particles. Higher
levels of Env could increase the infection efficiency of cells
that express low levels of receptor.
y 327 (2004) 16–25 21d for p27 content, filtered, and pelleted through 20% sucrose. Viral proteins
was detected by DA6 ascites (1:2000) and anti-mouse HRP (1:10,000). (B)
ey HRP.
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The Env proteins of many SIV and HIV-2 strains exhibit
variable degrees of CD4 independence, being able to cause
fusion with cells that are CD4-negative but that express
CCR5 or CXCR4 (Dumonceaux et al., 1998; Edinger et al.,
1997; Endres et al., 1996; Reeves and Schulz, 1997; Reeves
et al., 1997). A subset of these Envs can mediate CD4-
independent virus infection, although the presence of CD4
typically results in more efficient virus entry. In some cases,
this phenotype is associated with enhanced affinity for CD4
and a greater capacity to infect primary cell types that
exhibit low levels of this cell surface receptor. Rhesus
macaque alveolar macrophages, for example, express very
low levels of CD4 (Bannert et al., 2000; Mori et al., 1993).
Infection of these cells by macrophage tropic SIV strains
could result from the acquisition of CD4 independence or
from the ability to utilize the low levels of CD4 present on
these cells, perhaps from enhanced affinity for CD4, en-
hanced sensitivity to triggering by CD4, or some combina-
tion of these two. In addition, higher levels of Env on the
surface of SIVmac316 could also increase the efficiency of
virus entry when receptor levels are limiting.
CD4 independence does come with a cost, as viruses
capable of infecting cells independently of CD4 have thus
far been shown to be highly sensitive to antibody-mediated
neutralization (Kolchinsky et al., 2001; Puffer et al., 2002).
Stable exposure of the conserved coreceptor-binding site in
gp120 is at least one structural consequence of CD4
independence that likely contributes to neutralization sensi-
tivity (Hoffman et al., 1999). Thus, the humoral immune
response may exert strong selective pressure against the
evolution of CD4-independent HIV-1 strains. In this regard,
it is interesting to note that several viral isolates obtained
from brain tissue of patients with HIV-associated dementia
exhibited enhanced affinity for CCR5, the ability to bind
CCR5 in the absence of CD4, and enhanced sensitivity to
neutralization by several monoclonal antibodies (Gorry et
al., 2002). These results suggest that in antibody-privileged
sites such as the CNS or at late stages of disease in the face
of immune system collapse, HIV-1 strains that exhibit
reduced dependence on CD4 may evolve, expanding viral
tropism and contributing to the manifestations of AIDS.
Given the isolation of CD4-independent SIV and HIV-2
strains and primary HIV-1 strains with reduced CD4 depen-
dence, it is of interest to identify structural determinants that
contribute to this phenotype, not only to dissect the roles
that CD4 and coreceptor binding play in the entry processes,
but to better understand how CD4-independent viruses can
evolve in vivo. We found that only two substitutions within
the SIVmac239 Env were sufficient to impart a considerable
degree of CD4 independence as well as to render the Env
more sensitive to antibody-mediated neutralization. At the
minimum, the alteration in gp120 resulted in enhanced
affinity for rhesus CD4, a property associated with macro-
phage tropism in the SIV system that is perhaps neededbecause rhesus alveolar macaque macrophages have unde-
tectable levels of CD4 (Bannert et al., 2000; Mori et al.,
2000). Previously, it was shown that the 316 gp120 has a
higher affinity than 239 Env for human CD4 (Schenten et
al., 1999). However, it is not clear how a modest increase in
CD4 affinity alone could be important for imparting a CD4-
independent phenotype. Because Envs containing this mu-
tation were more sensitive to antibody-mediated neutraliza-
tion, it is possible that the M165I mutation may also result
in enhanced exposure of the coreceptor binding site formed
in part by the bridging sheet region of gp120. Exposure of
this domain has been documented in CD4-independent HIV-
1 strains and has been linked to neutralization (Edwards et
al., 2001; Hoffman et al., 1999).
For CD4-independent entry to occur, not only does Env
have to engage coreceptor in the absence of CD4, but this
binding event must trigger conformational changes in gp41
that result in membrane fusion (Moore and Doms, 2003). In
addition, CD4 binding is thought to induce exposure not only
of the coreceptor binding site in gp120, but the exposure of
the enfuvirtide (T-20) binding site in the HR1 domain of gp41
as well (Furuta et al., 1998). For CD4-independent viruses,
this change must be induced by coreceptor rather than CD4
binding. Therefore, it is perhaps not surprising that amino
acid changes are frequently found in the gp41 ectodomain of
CD4-independent Envs, either within or close to the HR1
domain. For example, HIV-2 ROD/B encodes two amino
acid substitutions essential for CD4 independence immedi-
ately flanking the ‘‘GIV’’ sequence of gp41, which has been
shown to function in resistance to the peptide fusion inhibitor
enfuvirtide (Derdeyn et al., 2001; Reeves and Schulz, 1997).
In the case of SIVmac316, we found that the K573Tmutation
played an important role in the CD4-independent phenotype
of the SIVmac316 Env protein. The mechanism by which
this mutation contributes to this phenotype is not clear, but
similar mutations have been found in other CD4-independent
HIV-1, HIV-2, and SIV strains (LaBranche et al., 1999; Lin et
al., 2001; Reeves and Schulz, 1997). We speculate that
mutations in the gp41 ectodomain could increase the effi-
ciency with which Env is triggered, or lower the energy bar-
riers such that coreceptor binding alone is sufficient to induce
the conformational changes needed for membrane fusion.
Passaging SIV in human cell lines frequently results in
truncation of the cytoplasmic domain in Env (Hirsch et al.,
1989). SIVmac316, which was obtained from infected
macaque macrophages, also possesses a shortened cytoplas-
mic domain and we found that this resulted in higher levels
of Env incorporation into virus particles. While not needed
for CD4-independent membrane fusion in cell–cell fusion
assays, truncation of the cytoplasmic domain resulted in a
significant increase in Env incorporation into virus particles.
Higher levels of Env would be expected to make the entry
process more efficient, particularly in the absence of CD4.
Without high-affinity CD4 binding, virus binding to the cell
surface would have to be mediated by attachment factors or
by coreceptor binding alone.
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that conversion of HIV-1, HIV-2, and SIV Envs from CD4-
dependent to CD4-independent phenotypes can occur via
multiple pathways, often involving only a few amino acid
changes in gp120 and gp41. Because these changes often
enhance neutralization sensitivity to a considerable degree,
the humoral immune response is apt to exert selective
pressure against this phenotype. However, in immune-
privileged sites or in situations where the humoral immune
response is weak, CD4-independent viruses that exhibit
expanded cellular tropism will be likely to emerge quickly.Materials and methods
Cell lines
293T and QT6 cells were obtained from the ATCC and
maintained in Dulbecco’s modified Eagle’s medium with
10% fetal calf serum and 10% penicillin/streptomycin.
Ghost cells were obtained from the AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID,
NIH, supplied by Dr. Vineet N. KewalRamani and Dr. Dan
R. Littman (Morner et al., 1999).
Plasmids
The SIVmac239 and SIVmac316 proviral plasmids were
kindly provided by Stefan Po¨hlmann. Proviruses containing
the positions 165 and 573 mutations were generated within
a SacI subclone of the provirus maintained the pLG338-30
plasmid. Mutated fragments were inserted into the provirus
using a SpeI partial digestion and BglII restriction site. Envs
were sequenced before production of replication-competent
virus. The pCDNA3.1+Zeo 239 and 316 gp160 expression
plasmid used for fusion assays have been described previ-
ously (Puffer et al., 2002). Point mutants were generated by
quickchange mutagenesis using the parental 239 and 316
gp160 expression plasmids as templates (Stratagene). The
nucleotide sequence of all Env expression clones was
confirmed by sequencing the entire gp160. Rhesus CD4IgG
was constructed by cloning the rabbit IgG heavy chain into
pcDNA3.1+Zeo (Invitrogen) from an SUA IgG expression
plasmid using the BamHI and EcoRI restriction sites (Zin-
gler and Young, 1996). A fragment containing domains 1
and 2 of rhesus CD4 was then amplified using the primers
CGGGGTACCGCCGCCACCATGAACCGGGGAATCC-
CTTTTAGGCACTTGCT and CGCGGATCCGGCCTTC-
TGGAAAGCTAGCACCACGAT, digested with KpnI and
BamHI and inserted into the rabbit heavy chain construct.
Cell–cell fusion assay
The ability of SIV envelope to mediate cell–cell fusion
was measured as described previously (Rucker et al.,
1997). Briefly, effector QT6 cells were infected withvaccinia virus expressing T7 polymerase (vTF1.1, Alexan-
der et al., 1992) then transfected with a pcDNA3 plasmid
encoding the indicated Env gene via the calcium phosphate
transfection method (Graham and van der Eb, 1973).
Target QT6 quail cells were transfected with plasmids
expressing CD4, coreceptor, and a T7-driven luciferase
reporter construct. Twenty-four hours post-infection or
-transfection, effector cells were added to the target cells
and subsequent fusion was quantitated 8 h post-mixing by
lysing cells with 0.5% Triton X-100. An aliquot of lysate
was then mixed with an equal volume of luciferase assay
reagent (Promega) and luminescence was measured in a
luminometer (Wallac).
Neutralization assay
Virus stocks were produced by calcium phosphate trans-
fection of HEK 293T cells. Virus stocks were normalized by
p27 ELISA and infectivity on GHOST cell lines expressing
human CCR5 and CD4. Virus was incubated with sera at the
designated concentration for 1 h at 37 jC and then added to
monolayers of GHOST target cells. Forty-eight hours post-
infection, cells were harvested with Versene (PBS–EDTA),
fixed in 2% paraformaldehyde, and analyzed by FACS.
Rhesus CD4 affinity ELISA
SIV gp120s were produced by vTF1.1 infection and
calcium phosphate transfection of 293T cells. Supernatants
were harvested from cells 48 h post-transfection and gp120
purified by lectin affinity column chromatography using
Galanthus nivalis agarose beads (Vector Labs) as previously
described (Hoffman et al., 1999). Purified proteins were
quantitated by BCA protein assay (Bio-Rad). ELISAs were
performed by coating 96-well plates with G. nivalis lectin
overnight at 4 jC. Plates were blocked with 2% BLOTTO in
TBS two times for 10 min each. Envelope protein was
diluted in BLOTTO to approximately 2 Ag/ml and 100
Al was applied to each well for at least 1 h at room
temperature. Plates were then washed six times with
PBS–Tween (KPL) and incubated for 1 h with serial
dilutions of supernatant from cells stably transfected with
the rhesus CD4IgG fusion construct under Zeocin selection.
Washing was repeated and plates were incubated with goat
anti-rabbit horseradish peroxidase (HRP)-conjugated anti-
body (Vector) at 1:10,000 dilution in BLOTTO for 1 h.
Plates were again washed and HRP detected using TM Blue
(KPL) with absorbance read in a Dynatech MLX plate
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